Untersuchung der Wirksamkeit einer glycerinhaltigen Creme bei der Behandlung von Atopischer Dermatitis. Kontrolliert, randomisierte Doppel-Blind-Studie.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-004443-22-DE

Enrollment

Registered

2005-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis MedDRA version: 7.0 Classification code 10012438

Interventions

Product Name: Glycerin Creme Product Code: D02 Pharmaceutical Form: Cream INN or Proposed INN: Glycerol CAS Number: 56-81-5 Current Sponsor code: E1000/239.00 Concentration unit: % percent Concentrati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: atopic dermatitis, informed consent, 12-50 years old, male or female Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: allergy against an ingredient, pregnancy, breastfeding, systemic illness, malignant tumor

Design outcomes

Primary

Measure	Time frame
Main Objective: barrier recovery in subjects with atopic dermatitis;Secondary Objective: reduction of inflammation, hydration of stratum corneum, stabilisation of skin-pH;Primary end point(s): end of study after 4 weeks of therapy and two weeks without treatment	—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026